United States · FDA National Drug Code directory

DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69367-184_4bb61a68-58fa-45ed-b9e8-4a5f83f7046b
Product NDC: 69367-184
Form: LIQUID
Composition / generic term: DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE
Labeler: Westminster Pharmaceuticals, LLC
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20180315
Source listing expiry: 20261231

Source-listed ingredients

DEXTROMETHORPHAN HYDROBROMIDE — 18 mg/15mL
GUAIFENESIN — 200 mg/15mL
PHENYLEPHRINE HYDROCHLORIDE — 10 mg/15mL

These values do not establish equivalence or a dose recommendation.

Packages

240 mL in 1 BOTTLE (69367-184-08) · 69367-184-08

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →